A phase II study of vorolanib in combination with toripalimab in patients with non-small cell lung cancer.

Jun Zhao,Jianjie Li,Hanxiao Chen,Xue Yang,Jia Zhong,Minglei Zhuo,Bo Jia,Tongtong An,Meina Wu,Ziping Wang,Lieming Ding,Li Mao

A phase II study of vorolanib in combination with toripalimab in patients with non-small cell lung cancer.

2021

Jun Zhao
Jianjie Li
Hanxiao Chen
Xue Yang
Jia Zhong
Minglei Zhuo
Bo Jia
Tongtong An
Meina Wu
Ziping Wang
Lieming Ding
Li Mao

e21053Background: VEGF promotes an immunosuppressive microenvironment and contributes to resistance of immune checkpoint inhibitors in cancer treatment. VEGF inhibitors have been shown to enhance e...

Keywords:

Cancer research
VEGF receptors
in patient
Lung cancer
Medicine
non small cell
cancer treatment
immune checkpoint inhibitors
Phases of clinical research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations